Antidiabetic Effects of the Senolytic Agent Dasatinib
Omid Salaami, Chia‐Ling Kuo, Matthew T. Drake, George A. Kuchel, James L. Kirkland, Robert J. Pignolo
Topics & Concepts
MedicineDasatinibInternal medicineDiabetes mellitusWeight lossTyrosine-kinase inhibitorEndocrinologyType 2 Diabetes MellitusImatinibHemoglobinType 2 diabetesGastroenterologyPharmacologyCancerObesityMyeloid leukemiaChronic Myeloid Leukemia TreatmentsDiabetes Treatment and ManagementMetabolism, Diabetes, and Cancer